Pharmacokinetics of Monoclonal Antibodies
- 1 July 1996
- journal article
- review article
- Published by Springer Nature in Clinical Immunotherapeutics
- Vol. 6 (1), 54-67
- https://doi.org/10.1007/bf03259352
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Tumor targeting: Activation of prodrugs by enzyme-monoclonal antibody conjugatesTrends in Biotechnology, 1994
- Phage libraries for generation of clinically useful antibodiesThe Lancet, 1994
- Tumour necrosis factor increases tumour uptake of Co-administered antibody-carboxypeptidase G2 conjugateEuropean Journal Of Cancer, 1993
- Immunotoxins: magic bullets or misguided missiles?Immunology Today, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Preparation, characterization, and in vivo biodistribution properties of synthetically cross-linked multivalent antitumor antibody fragmentsBioconjugate Chemistry, 1993
- Monoclonal Antibody AdministrationClinical Pharmacokinetics, 1992
- The effect of radiosensitizers on radio‐immunotherapy, using 131I‐Labelled anti‐cea antibodies in a human colonic xenograft modelInternational Journal of Cancer, 1991
- A fluorouridine-anti-CEA immunoconjugate is therapeutically effective in a human colonic cancer xenograft modelInternational Journal of Cancer, 1990
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990